Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000735137 | SCV000863338 | uncertain significance | not provided | 2018-09-13 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001078977 | SCV001019112 | likely benign | Duchenne muscular dystrophy | 2024-09-12 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV001000447 | SCV001157273 | likely benign | not specified | 2018-12-06 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002406674 | SCV002719434 | likely benign | Cardiovascular phenotype | 2020-03-16 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Natera, |
RCV001276608 | SCV001463037 | likely benign | Dystrophin deficiency | 2020-04-11 | no assertion criteria provided | clinical testing |